Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Voom LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being processed by 1 distinct examiner in 1 distinct art unit. The active prosecution is currently focused on one filing. This concentration means that the outcome of the company's active patent efforts depends on the findings of a specific administrative group. Such a narrow focus allows the applicant to dedicate resources to a specific technical dialogue. The alignment of the technical subject matter within the specified group suggests a focused patenting strategy for the biotechnology technology.
LAURA LYNNE STOCKTON is the busiest examiner for the company, holding 1 pending office action. Because there is only 1 distinct examiner, this individual handles the entire pending workload. The 1 distinct art unit indicates the technology is classified within one specific biotechnology examination unit. For the applicant, this suggests a focused prosecution environment where consistency in examiner communication is paramount. The limited scope of the current activity simplifies the management of the portfolio. This examiner handles the total active matters for the firm, ensuring that all feedback is filtered through a specific professional perspective.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOCKTON, LAURA LYNNE | 1 | 75.3% | +33.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279988 | COMPOSITIONS AND METHODS FOR TREATMENT OF BLEPHARITIS | STOCKTON, LAURA LYNNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279988 | COMPOSITIONS AND METHODS FOR TREATMENT OF BLEPHARITIS | STOCKTON, LAURA LYNNE | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18279988 | COMPOSITIONS AND METHODS FOR TREATMENT OF BLEPHARITIS | STOCKTON, LAURA LYNNE | 1626 | §102§103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVoom LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Laura Lynne Stockton has the most, with 1 of Voom LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
